Understanding Women’s Bodies
For decades, new therapies were routinely tested only in men, and assumed to work the same way in women. The landmark NIH Revitalization Act, with its requirement that women be included in clinical trials, rang in a new era. But on the law’s 30th anniversary, progress remains incomplete. Research into many conditions that primarily affect women are underfunded, findings are often reported in ways that make it impossible to distinguish gender differences, medical practices lag new knowledge, and cardiovascular disease remains the leading killer of women. Improving the health of half the world’s population depends on deeper commitments on multiple fronts.